FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes First and only oral antidiabetic fixed-dose combination medication ...
LINCOLNSHIRE, Ill., November 1, 2005 – Takeda Pharmaceuticals North America, Inc. today announced that ACTOplus met TM (pioglitazone HCl and metformin HCl) is now available by prescription in ...
ACTOplus met XR (pioglitazone HCl/metformin HCl extended-release tablets, from Takeda) has been FDA approved as an adjunct to diet and exercise for the treatment of type 2 diabetes. ACTOplus met XR is ...
Actos (pioglitazone) is a prescription drug that’s used to help manage blood sugar levels in people with type 2 diabetes. Actos can cause side effects that range from mild to serious. Examples include ...
Takeda granted generics firm Teva a license to market authorized copies in the US, starting Aug. 17, 2012, for best-selling diabetes pill Actos, and on Dec. 14, 2012, for Actoplus met (Actos plus ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Adults with type 2 diabetes randomly ...
Actos (pioglitazone) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as an oral tablet that’s taken once per day. Actos is used to help manage blood sugar levels in adults ...
March 9, 2007 — Pioglitazone therapy may be linked to an increased risk for fracture in women, warns the US Food and Drug Administration (FDA) and Takeda. The warning is based on data from the company ...
Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
BOSTON, April 30, 2004 – Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride ...
Metformin and pioglitazone showed anti-inflammatory effects in patients with multiple sclerosis and metabolic syndrome, according to a new study published in JAMA Neurology. Metformin and pioglitazone ...
People taking the diabetes drug may have an increased risk of bladder cancer. June 16, 2011— -- Patients taking the diabetes drug Actos for more than a year may have an increased risk of bladder ...
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes First and only oral antidiabetic fixed-dose combination medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback